HDAC9 and neoplasm: HDAC inhibitors can specifically inhibit HDAC activity, prevent excessive histone deacetylation, restore its acetylation to the normal level, thereby loosening the chromatin structure and reactivating tumor suppressor genes (Carraway and Gore, 2007).